CAR-T Therapy: CNS Lymphoma Patient Achieves Two-Year Remission
India
- 9 days ago
Discover how a patient with relapsed CNS lymphoma achieved two years of complete remission after receiving CAR-T therapy (NexCAR19) in India. This case highlights the growing success of advanced cell therapies in treating aggressive cancers and offering durable outcomes.